Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 7
2017 5
2018 5
2019 4
2020 1
2021 11
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality.
Farinea G, Crespi V, Listì A, Righi L, Bironzo P, Merlini A, Malapelle U, Novello S, Scagliotti GV, Passiglia F. Farinea G, et al. Among authors: listi a. J Thorac Oncol. 2023 Sep;18(9):1146-1164. doi: 10.1016/j.jtho.2023.05.028. Epub 2023 Jun 16. J Thorac Oncol. 2023. PMID: 37331604 Free article. Review.
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity.
Bersani F, Picca F, Morena D, Righi L, Napoli F, Russo M, Oddo D, Rospo G, Negrino C, Castella B, Volante M, Listì A, Zambelli V, Benso F, Tabbò F, Bironzo P, Monteleone E, Poli V, Pietrantonio F, Di Nicolantonio F, Bardelli A, Ponzetto C, Novello S, Scagliotti GV, Taulli R. Bersani F, et al. Among authors: listi a. J Exp Clin Cancer Res. 2023 May 12;42(1):120. doi: 10.1186/s13046-023-02690-5. J Exp Clin Cancer Res. 2023. PMID: 37170152 Free PMC article.
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer.
Listì A, Barraco N, Bono M, Insalaco L, Castellana L, Cutaia S, Ricciardi MR, Gristina V, Bronte E, Pantuso G, Passiglia F. Listì A, et al. Transl Cancer Res. 2019 Jan;8(Suppl 1):S55-S63. doi: 10.21037/tcr.2018.10.04. Transl Cancer Res. 2019. PMID: 35117064 Free PMC article. Review.
Repositioning PARP inhibitors in the treatment of thoracic malignancies.
Passiglia F, Reale ML, Cetoretta V, Parlagreco E, Jacobs F, Listì A, Righi L, Bironzo P, Novello S, Scagliotti GV. Passiglia F, et al. Among authors: listi a. Cancer Treat Rev. 2021 Sep;99:102256. doi: 10.1016/j.ctrv.2021.102256. Epub 2021 Jul 7. Cancer Treat Rev. 2021. PMID: 34261032 Review.
Nintedanib in NSCLC: evidence to date and place in therapy.
Bronte G, Passiglia F, Galvano A, Barraco N, Listì A, Castiglia M, Rizzo S, Fiorentino E, Bazan V, Russo A. Bronte G, et al. Among authors: listi a. Ther Adv Med Oncol. 2016 May;8(3):188-97. doi: 10.1177/1758834016630976. Epub 2016 Feb 16. Ther Adv Med Oncol. 2016. PMID: 27239237 Free PMC article. Review.
Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D, Barraco N, Listì A, Bazan V, Russo A. Fanale D, et al. Among authors: listi a. Adv Exp Med Biol. 2016;937:93-108. doi: 10.1007/978-3-319-42059-2_5. Adv Exp Med Biol. 2016. PMID: 27573896 Review.
42 results